Physician profile
Mark W Hatch
NPI 1821089145
$4,290.25
in general payments reported to CMS, 2019-2025
16 companies · $1,393 in 2025
The $1,393 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $59.27 · 2021: $252 · 2022: $459 · 2023: $1,231 · 2024: $673 · 2025: $1,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,721 · Travel and Lodging: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,720.71 |
| Travel and Lodging | $576.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,672.54 | 2022-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $750.91 | 2019-2025 | Dupixent |
| Genzyme Corporation | $555.69 | 2022-2025 | |
| Glaxosmithkline, LLC. | $290.47 | 2021-2025 | Nucala |
| Medtronic, INC. | $265.73 | 2025 | Propel, Sinuva, Nuvent |
| Optinose US, INC. | $155.57 | 2019-2022 | |
| Alk-Abello, INC | $132.36 | 2022-2023 | Ragwitek, Odactra, Grastek |
| Kaleo, INC. | $110.77 | 2019-2021 | |
| Stryker Corporation | $108.73 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $88.22 | 2021 | |
| Arbor Pharmaceuticals, INC. | $37.59 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.52 | 2022-2023 | |
| Phathom Pharmaceuticals, INC. | $31.57 | 2024-2025 | Voquezna |
| Zoll Respicardia, INC. | $24.50 | 2024 | Remede System |
| Resmed Corp | $15.72 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $14.36 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hatch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.